NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/20/2024
Back to search
Official data from USPTO
REBOUND THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REBOUND THERAPEUTICS
ST13
US500000086815157Class
10
Filing
86815157
Registration
5396887
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
08/20/2024
Trademark type
Word
Nice classes
10
Filing date
11/10/2015
Registration date
02/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
08/20/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/27/2017
First use in commerce
04/27/2017
Drawing code
4
Owner type
03
Owner location
Irvine, CA
Examiner
STRINGER, DANIEL
Current location
Historical data usage
Holders and representatives
Holders
R. C. (pessoa física)
Representatives
Eva Tan Integra LifeSciences Corporation
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Devices for localizing the blood mass of an intracerebral hematoma; devices for extracting an intracerebral hematoma
Publications
History of USPTO decisions and trademark events.
42 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/20/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/20/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/05/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/31/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/31/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/31/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/31/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/31/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/03/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/02/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/22/2017
EEXT
SOU TEAS EXTENSION RECEIVED
12/21/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2017
EX2G
SOU EXTENSION 2 GRANTED
05/31/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/30/2017
EXT2
SOU EXTENSION 2 FILED
05/19/2017
EEXT
SOU TEAS EXTENSION RECEIVED
05/19/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/18/2017
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/18/2017
IUAF
USE AMENDMENT FILED
05/01/2017
EISU
TEAS STATEMENT OF USE RECEIVED
05/01/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/20/2016
EX1G
SOU EXTENSION 1 GRANTED
12/16/2016
EXT1
SOU EXTENSION 1 FILED
12/16/2016
EEXT
SOU TEAS EXTENSION RECEIVED
12/16/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/21/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2016
PUBO
PUBLISHED FOR OPPOSITION
04/26/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/22/2016
ALIE
ASSIGNED TO LIE
03/21/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2016
DOCK
ASSIGNED TO EXAMINER
03/03/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/13/2015
NWAP
NEW APPLICATION ENTERED
11/13/2015
Continuous trademark protection
Get notified about every new filing that threatens REBOUND THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.